XTX Topco’s C4 Therapeutics CCCC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $155K | Buy |
108,278
+68,178
| +170% | +$97.5K | 0.01% | 1780 |
|
|
2025
Q1 | $64.2K | Buy |
+40,100
| New | +$64.2K | ﹤0.01% | 1956 |
|
|
2024
Q4 | – | Sell |
-84,951
| Closed | -$484K | – | 2339 |
|
|
2024
Q3 | $484K | Buy |
+84,951
| New | +$484K | 0.04% | 840 |
|
|
2024
Q1 | – | Sell |
-21,203
| Closed | -$120K | – | 1877 |
|
|
2023
Q4 | $120K | Sell |
21,203
-74,839
| -78% | -$423K | 0.03% | 1095 |
|
|
2023
Q3 | $179K | Sell |
96,042
-104,991
| -52% | -$195K | 0.03% | 1053 |
|
|
2023
Q2 | $553K | Buy |
201,033
+167,194
| +494% | +$460K | 0.1% | 308 |
|
|
2023
Q1 | $106K | Buy |
33,839
+19,685
| +139% | +$61.8K | 0.02% | 1091 |
|
|
2022
Q4 | $83.5K | Buy |
14,154
+1,605
| +13% | +$9.47K | 0.02% | 1016 |
|
|
2022
Q3 | $110K | Buy |
+12,549
| New | +$110K | 0.03% | 930 |
|